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ABSTRACT
Objective To examine surgical outcomes and trends in 
the implementation of minimally invasive surgery (MIS) 
use for endometrial cancer (EC).
Design Retrospective cohort study.
Setting English National Health Service hospitals 2011–
2017/2018.
Population 35 304 patients having a hysterectomy for EC 
identified from Hospital Episode Statistics.
Methods Univariate and multivariate analyses 
compared MIS to open hysterectomy (OH) by assessing 
the association between demographic, clinical and 
hospital characteristics by using logistic regression. A 
propensity score was created, to control for confounding 
factors including demographics, clinical and hospital 
characteristics, from a logistic regression which enabled 
the inverse probability weighting of treatment to be applied 
in order to compare outcomes of treatment.
Main outcome measures The association between route 
of surgery on perioperative morbidity and mortality.
Results The MIS rate rose from 40.3% in 2011 to 68.7% 
in 2017/2018, however, there was significant geographical 
variation (p<0.001). The overall 90- day mortality was 
significantly higher with OH versus MIS (OR 0.34, 95% CI 
0.18 to 0.62, p=0.0002). MIS rates were significantly 
lower in patients from the lowest socioeconomic group 
(LSEG) compared with patients from the highest group 
(HSEG) (55.4% vs 59.9%, p<0.01), and in the black 
population as compared with white and Asian populations 
(40.4% vs 58.6% and 56.0%, p<0.0001). When patients 
from LSEG and black patients were treated in hospitals 
with high MIS rates, the MIS rate increased close to that of 
the HSEG and white patients (81.0% and 74.1% vs 83.2% 
and 82.6%).
Conclusions Further investigation is needed to 
understand the barriers to MIS and improve access so that 
as many patients as possible can benefit from the reduced 
morbidity/mortality associated with MIS.
INTRODUCTION
There are estimated to be 382 069 new cases 
of endometrial cancer (EC) and 89 929 
deaths worldwide in 2018.1 The incidence 
of EC in the UK is rising,2 attributed due 
to increasing rates of obesity, an ageing 
population and falling hysterectomy rates 
for benign disease.3 4 Surgery remains the 
primary treatment option,5 particularly for 
early- stage EC which is associated with a 
high overall survival rate. However, a less 
favourable benefit/risk profile for surgical 
outcomes exists in an elderly population with 
multiple comorbidities, where consideration 
is needed as to whether surgical morbidity 
and mortality would be higher than the risk 
of recurrence associated with non- surgical 
treatment options.5
The benefit of minimally invasive surgery 
(MIS) over traditional open surgery for EC has 
been firmly established with non- inferiority 
of survival and recurrence rates, and signifi-
cantly lower levels of postoperative compli-
cations.6–8 Initially studies were confined to 
Strengths and limitations of this study
 ► The main strength of this study is that it is popula-
tion based and the large number of procedures has 
enabled trends to be identified that may not have 
been seen in smaller datasets.
 ► Hospital Episode Statistics (HES) data only cov-
ers National Health Service (NHS)‐funded care in 
England, therefore, data on hysterectomies under-
taken outside of the NHS were not included in this 
study.
 ► The reliability of the coding might have changed 
over time although there was no evidence of chang-
es in treatment coding or significant changes in the 
underlying study population.
 ► HES database reliably captures extensive amount of 
demographic, diagnosis and procedure outcomes, 
however, there is a lack of cancer stage information 
therefore it is possible some of the deaths may have 
been due to disease progression rather as a result 
of surgery.
 ► Not all deaths are captured in the HES database, 
only those which occurred in hospital which limits 
the death data captured in the HES database.
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early stage endometrioid cancers,7 9 however, as the MIS 
skills of gynaecologists have developed enabling more 
extensive surgery, including pelvic/para- aortic lymph 
node dissection, this evidence has been extended to high- 
risk subtypes and more advanced disease.10 As a result, 
MIS is the advocated as the preferred surgical route for 
the management of endometrial malignancy.11 12
The surgical management of EC in the UK is divided 
between satellite cancer units and central cancer centres, 
following the recommendations from the Calman Hine 
report in 1995.13 Cancer units typically manage early- 
stage, low- grade cases and refer complex or higher stage/
grade cases to their affiliated regional cancer centre. The 
adoption of MIS by the gynaecological oncology commu-
nity is increasing, particularly for the treatment of EC,14 
however, national data from the USA in 2016 showed that 
the open hysterectomy (OH) was still the most common 
procedure rather than MIS.15 Similarly, across the UK the 
uptake of MIS hysterectomy has been variable and signif-
icant regional differences exist.16
We performed an analysis using Hospital Episode 
Statistics (HES) for England.17 Our primary objective 
was to examine trends in the implementation of MIS use 
in EC across England. Our secondary objectives were 
to examine predictors of uptake of MIS and to further 
explore the association between route of surgery on 
perioperative morbidity and mortality.
METHODS
Data source
Data were sourced from the HES database to conduct 
a retrospective cohort analysis from 2011–2017/2018.17 
No ethical approval was required for this study. The 
data were accessed by GM and analysed by GM and AM. 
Access to the data and HCD economics were funded by 
Intuitive Surgical. None of the clinicians involved in this 
study received any funding from Intuitive Surgical for this 
study. Intuitive Surgical did not have access to the data 
or involvement with the study design, data analysis and 
writing of the manuscript.
Cohort selection
From the HES database, an extracted dataset was created 
to only include patients that had specific Office of Popu-
lation Censuses and Surveys Classification of Interven-
tions and Procedures V.4.7 (OPCS-4.7) procedure codes 
which indicated they had a hysterectomy between the 
dates of October 2011 and December 2017. The specific 
OPCS-4.7 codes were: Q07.1, Q07.2, Q07.3, Q07.4, Q07.5, 
Q07.8, Q07.9, Q08.1, Q08.2, Q08.3, Q08.8 and Q08.9. 
The cohort of female patients was then restricted to be 
greater or equal to 18 years of age and further by using 
International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision (ICD-10) primary 
diagnosis codes to identify patients where the indication 
was endometrial/uterine carcinoma or endometrial 
carcinoma in situ (ECIS) (complex atypical hyperplasia) 
(C540, C541, C542, C543, C548, C549, C55X and D070).
To classify the hysterectomy approach in terms of inten-
tion to treat, we used additional OPCS-4.7 codes. To iden-
tify laparoscopic hysterectomy (LH) the OPCS-4.7 codes 
were Y75.1, Y75.2, Y75.5, Y75.8, Y75.9, T43.9 and for 
robotic hysterectomy (RH) the OPCS-4.7 code Y75.3 was 
used. As a result, MIS is a combination of all the additional 
OPCS-4.7 codes. The remainder that did not have any of 
the additional OPCS-4.7 codes were classified based on 
the original procedure codes for the approaches of OH 
(Q07.1, Q07.2, Q07.3, Q07.4, Q07.5, Q07.8 and Q07.9) 
and vaginal hysterectomy (VH) (Q08.1, Q08.2, Q08.3, 
Q08.8 and Q08.9). In the cases where the OPCS-4.7 code 
Y71.4 (Failed minimal access approach converted to 
open) was recorded, and no MIS approach codes were 
reported alongside. A method to assign intention to treat 
as LH until the National Health Service (NHS) providers 
introduced robotic assisted surgery equipment and then 
classify intention to treat as robotic thereafter.
Patient characteristics
Demographic data that were collected included age, 
which was divided into 6 groups by 10- year intervals from 
the age of 50. Ethnicity data were collected and patients 
were grouped into Asian, black, other and white ethnicity.
The English Index of Multiple Deprivation (IMD)18 
for 2015 was collected to inform the socioeconomic 
deprivation of patients where a higher rank indicated a 
less deprived group and a lower rank indicated a more 
deprived group. The IMD score combines seven indicators 
(income, employment, health deprivation and disability, 
education, skills and training, barriers to housing and 
services, crime, and living environment), into a single 
deprivation index. The IMD ranks were then split into 
statistical quartiles to indicate whether the socioeconomic 
status was high (>25 083), intermediate (17 475–25083), 
low (9618–17474) or very low (<9618). Based on postcode 
of residence, each patient who received EC surgery was 
assigned to a lower super output area (LSOA) and this 
was mapped to an IMD rank calculated across the whole 
of England using this measure.
Comorbidities were examined using the Charlson 
Comorbidity Index (CCI)19 and an additional list of other 
comorbidities were assessed using a list of ICD-10 codes.20
Hospital characteristics were evaluated for the region 
where the procedure took place and was classified into 
10 groups (East, East Midlands, Greater London, Home 
Counties, North East, North West, South East, South West, 
West Midlands, Yorkshire). The hospital volume was also 
analysed as an annual mean across years (if more than 
1 year was available) of all hysterectomies performed for 
EC/ECIS at the providers and grouped by statistical quar-
tiles; high (>220), intermediate (71–220), low (70–21) 
and very low (0–20). In addition, each NHS hospital 
provider was classified by their MIS rate for hysterecto-
mies performed on EC/ECIS and split into four groups: 
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very low 0%–25%, low 26%–50%, intermediate 51%–75%, 
high 76%–100%.
Outcomes
To analyse the trend of surgeries the number of proce-
dures by each approach was assessed each year to see 
how practice had changed. The key surgical outcomes 
of interest were mortality and complications associated 
with each approach following the procedure. A list of 
complications were collated (ICD-10/OPCS-4.7 codes) 
for complication groups of gastrointestinal, wounds, 
infections, renal/genitourinary and endocrine, cardio-
vascular, pulmonary, neurological, haemorrhage, 
urinary tract, ureteric and other. These were assessed 
as perioperative (within the intervention admission) 
and at 90 days following intervention to ensure a long 
enough follow- up period to be assessed after surgery.21 
Perioperative outcomes included mortality, conversion 
to OH, recorded complications and length of stay. The 
90- day outcomes also included in- hospital mortality and 
reported complications following the intervention. To 
assess disparities outcomes were assessed by regional vari-
ations at the patient level and additionally the provider 
level. Subgroup analysis was undertaken to compare the 
outcomes of high versus low socioeconomic groups and 
black ethnicity versus other ethnicities.
Statistical analyses
A descriptive analysis of patient characteristics and 
outcomes was performed. The different approaches (LH, 
RH, OH and MIS) were then compared by using t- test 
(for independent samples) and Wilcoxon rank- sum test 
(Mann- Whitney U test) for continuous variable and for 
categorical variables by using the χ2 tests. Univariate and 
multivariate analyses compared MIS to OH and RH to 
OH by assessing the association between demographic, 
clinical and hospital characteristics by using a logistic 
regression. Based on the predicted probability, a propen-
sity score was created from the logistic regression which 
included year of surgery, age groups, ethnicity, IMD rank 
groups, CCI group, region and provider volume. The 
predicted probabilities enabled the inverse probability 
weighting of treatment (IPTW) to be applied to balance 
observed confounders between the treatments.22 To 
ensure balance of the measured covariate distribution 
between treatment groups, the standardised mean differ-
ence was assessed using a threshold for mean difference 
of 0.1.23 24 Application of the IPTW was then used on 
comparing outcomes of treatment. Missing data of any 
of the propensity score variables were not imputed and 
patients with missing data were removed from propensity 
score matching. All descriptive and regression analyses 
were performed using Stata V.15.
Patient and public involvement
There was no patient or public involvement in the study 
planning or design.
RESULTS
A total of 35 304 procedures were performed, 20 405 
(57.8%) were MIS (LH 18 604 and RH 1801), 14 291 
(40.5%) OH and 608 (1.7%) VH. Due to the low numbers 
the VH cases were not included in the analysis. The rate 
of MIS rose from 40.3% to 68.7% across the study period 
(p<0.001), with RH increasing from 0.7% in 2011/12% to 
8.2% in 2016/17 (p<0.001), whereas the rate of OH fell 
from 59.7% in 2011/12 to 31.3% in 2016/17 (p<0.001) 
(figure 1). Lymph node dissection was performed in 
18.4% of OH and 15.6% of MIS (14.6% LH, 25.3% RH) 
cases.
Table 1 presents the unadjusted and IPTW patient char-
acteristics of those that received MIS or OH. Comparison 
of the unadjusted results of MIS and OH cases on patient 
characteristics identified that the OH group contained 
patients who were on average younger (66.1 vs 65.7 years, 
p=0.0052), of non- white ethnicity (p<0.001) and on 
average from a lower socioeconomic group (17 483 vs 16 
788, p<0.001). There was no difference in the levels of 
obesity (24.0% vs 23.6%, p=0.504) between MIS and OH, 
however, there was a difference in the CCI score, (1.41 vs 
1.52, p<0.001).
This was confirmed in the multivariate regression which 
found that a patient was more likely to receive MIS if the 
surgery was performed more recently, they were aged 
between 50 and 90 years and had the procedure under-
taken in the North East or South West of England (p<0.001 
for all: online supplementary appendix 1). Whereas a 
patient was more likely to receive OH if they attended 
a very low volume centre, were from a very low socio-
economic group, were of black or Other ethnicity, and 
located in the North West or West Midlands of England 
(p<0.001 for all: online supplementary appendix 2).
Figure 1 Route of hysterectomy by year. The route of 
surgery for endometrial cancer over time. LH, laparoscopic 
hysterectomy; MIS, minimally invasive surgery; OH, open 
hysterectomy; RH, robotic hysterectomy.
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Table 1 Clinical and demographic characteristics by the cohorts of hysterectomy approach










P valueCharacteristics No % No % No % No %
NHS year of surgery
  2011/2012* 1127 6 1671 12 1305 8 1306 8
  2012/2013 2471 12 2829 20 2566 15 2561 15
  2013/2014 2971 15 2614 18 2677 16 2676 16
  2014/2015 3387 17 2361 17 2772 17 2782 17
  2015/2016 3500 17 1948 14 2635 16 2623 16
  2016/2017 4060 20 1852 13 2846 17 2848 17
  2017/2018* 2889 14 1016 7 <0.001 1858 11 1828 11 0.812
Age, years
  <50 1153 6 1082 8 1052 6 1056 6
  50–59 4317 21 3098 22 3568 21 3583 22
  60–69 7111 35 4672 33 5683 34 5664 34
  70–79 5693 28 3779 26 4541 27 4527 27
  80–89 2020 10 1540 11 1702 10 1682 10
  90> 111 1 120 1 <0.001 113 1 111 1 0.765
Ethnicity
  White 16 453 81 11 117 78 13 272 80 13 222 80
  Asian 649 3 499 3 539 3 544 3
  Black 251 1 365 3 289 2 285 2
  Other 3052 15 2310 16 <0.001 2559 15 2573 15 0.785
Socioeconomic group (IMD)
  High 5149 25 3291 23 4194 25 4201 25
  Intermediate 5015 25 3387 24 4142 25 4124 25
  Low 4924 24 3489 24 4134 25 4109 25
  Very low 4768 23 3703 26 <0.001 4188 25 4190 25 0.962
Charlson comorbidity group
  0 23 0 13 0 16 0 17 0
  1 13 591 67 8405 59 10 577 63 10 550 63
  2 5429 27 4535 32 4767 29 4769 29
  ≥3 1362 7 1338 9 <0.001 1299 8 1288 8 0.966
Region
  GLondon 2848 14 2184 15 2419 15 2421 15
  Yorks 1771 9 1220 9 1488 9 1512 9
  WestMid 1901 9 1672 12 1734 10 1739 10
  SouthWest 2751 13 1348 9 1981 12 1936 12
  SouthEast 2085 10 1451 10 1675 10 1645 10
  NorthWest 2909 14 2550 18 2624 16 2624 16
  NorthEast 1402 7 432 3 855 5 860 5
  Hcounties 1126 6 912 6 968 6 970 6
  EastMid 1650 8 1003 7 1289 8 1292 8
  East 1926 9 1497 10 1627 10 1625 10
  Missing 36 0 22 0 <0.001 – – – – 0.957
Continued
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Surgical morbidity and mortality
A significant difference was seen in the perioperative 
outcome of the different routes of surgery. The length of 
hospital stay was significantly longer for OH as compared 
with MIS (5.28 vs 2.32 days, p<0.001). The overall conver-
sion rate to OH for MIS was 6.6%. IPW analysis identified 
that the only peri- operative complication that was not 
significantly higher with OH as compared with MIS was 
ureteric complications (p<0.001 for all other complica-
tions: table 2). The surgical complications requiring read-
mission/reintervention in 90 days were also significantly 
higher (9.6% vs 5.5%, p<0.001) in the OH cohort.
The overall mortality up to 90 days after surgery 
following IPTW was significantly higher with OH rather 
than MIS (OR 0.34; 95% CI 0.18 to 0.62; p=0.0002: 
table 2). This relationship was accentuated when 
comparing RH versus OH (OR 0.04; 95% CI 0 to 0.27; 
p<0.001). The patients who died in the 90- day period 
following surgery were older (70.6 vs 70.4 years, 
p=0.0012) and had more comorbidities, in partic-
ular diabetes (p=0.024) hypertension (p=0.018), renal 
failure (p=0.001) and angina (p=0.017), compared with 
patients who did not die.










P valueCharacteristics No % No % No % No %
Provider volume
  High 12 725 62 8703 61 10 445 63 10 456 63
  Intermedate 7140 35 5102 36 5937 36 5894 35
  Low 288 1 191 1 232 1 231 1
  Very low 36 0 58 0 46 0 43 0
  Missing 216 1 237 2 <0.001 – – – – 0.712
*NHS year 2011/2012 and 2017/2018 not full year.
IMD, Index of Multiple Deprivation; IPTW, inverse probability weighting of treatment; MIS, minimally invasive surgery; NHS, National Health 
Service.
Table 1 Continued
Table 2 Comparison of mortality and complications at intervention between MIS and OH cohorts
Unadjusted results IPTW results
MIS OH
P value
MIS versus OH MIS OH
P value
MIS versus OH
No % No % OR (95% CI) No % No % OR (95% CI)
Death 
(intervention)
9 0 18 0 0.007 0.35 (0.14 to 0.82) 8 0 25 0 0.003 0.32 (0.12 to 0.73)
Death (overall)* 17 0 44 0 <0.001 0.27 (0.14 to 0.48) 15 0 44 0 <0.001 0.34 (0.18 to 0.62)
Any complication 
(intervention)
4305 21 4012 28 <0.001 0.54 (0.51 to 0.57) 3503 21 4725 28 <0.001 0.67 (0.64 to 0.71)
Specific complications (intervention)
  Gastrointestinal 1637 8 1185 8 <0.001 0.61 (0.57 to 0.66) 1275 8 1479 9 <0.001 0.85 (0.79 to 0.92)
  Wounds 325 2 679 5 <0.001 0.20 (0.17 to 0.23) 276 2 783 5 <0.001 0.34 (0.30 to 0.39)
  Infections 360 2 815 6 <0.001 0.16 (0.14 to 0.19) 296 2 913 5 <0.001 0.31 (0.27 to 0.36)
  Urinary 623 3 786 5 <0.001 0.26 (0.24 to 0.29) 514 3 899 5 <0.001 0.56 (0.50 to 0.62)
  Ureteric 6 0 8 0 0.005 0.25 (0.07 to 0.82) 4 0 8 0 0.247 0.50 (0.11 to 1.86)
  Cardiovascular 1255 6 1162 8 <0.001 0.30 (0.27 to 0.32) 1047 6 1340 8 <0.001 0.77 (0.70 to 0.83)
  Pulmonary 305 1 587 4 <0.001 0.13 (0.11 to 0.15) 262 2 676 4 <0.001 0.38(0.33 to 0.44)
  Neurological 84 0 111 1 <0.001 0.18 (0.14 to 0.24) 77 0 120 1 0.002 0.64 (0.47 to 0.86)
  Haemorrhage 199 1 270 2 <0.001 0.17 (0.14 to 0.20) 169 1 310 2 <0.001 0.54 (0.44 to 0.65)
  Other 736 4 646 5 <0.001 0.22 (0.20 to 0.25) 593 4 786 5 <0.001 0.74 (0.67 to 0.83)
*Death (overall) Includes death at intervention and deaths reported 90 days after intervention.
IPTW, inverse probability weighting of treatment; MIS, minimally invasive surgery; OH, open hysterectomy.
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Regional variation
The MIS rate increased year on year across all regions, 
however, the uptake varied significantly between 
geographical regions (p<0.001; table 1). Very low volume 
centres (<20 cases per year) had a significantly lower MIS 
rate compared with the other quartiles, 37.5% vs 58.9% 
for low, 56.7% intermediate and 58.9% for high, (p<0.05 
for all). Provider level analysis showed only 55 centres 
had high MIS levels for EC (>76.0% MIS rate) and there 
was a large disparity between regions (figure 2). Over 
time the age of the patients undergoing MIS increased 
and by 2017 was the median age was higher than for OH 
cases, with the greatest increase being seen in the high 
MIS providers. The CCI of patients undergoing surgery 
(any route) between 2011 and 2018 also increased year 
on year, however, at high and intermediate MIS centres 
the ratio between CCI of OH and MIS patients became 
smaller (1.06 in 2011 to 1.02 in 2017). In addition, there 
was great variability across providers and regions as to the 
proportion of MIS implemented, with 78% of providers 
achieving a 50% threshold but only 56% passing a 70% 
threshold (figure 3).
Disparity in MIS rates
Disparity was seen in the MIS rates in patients from the 
lowest socioeconomic group as compared with patients 
from the highest group (55.4% compared with 59.9%, 
p<0.01). Patients from this group were younger compared 
with patients in the high socioeconomic group(64.3 vs 
67.0 years, p<0.01) but had a higher level of comorbidi-
ties (1.56 vs 1.39, p<0.01). When patients from the lowest 
socioeconomic group were treated in high MIS centres 
the MIS rate increased to 81.0%, close to the rate in 
patients from the highest socioeconomic group 83.2%.
Black patients undergoing surgery were significantly 
younger than patients from other ethnic groups (63.7 
vs 66.0, p<0.001), were mainly located in more deprived 
areas (85.9% in low or very low socioeconomic status) 
and had more comorbidities as compared with the 
overall population cohort (1.65 vs 1.45, p<0.001). The 
MIS rates were significantly lower in the black popula-
tion as compared with the white and Asian populations, 
40.4% as compared with 58.6% and 56.0%, respectively 
(p<0.001). A significantly higher percentage of white 
patients (21.2%) attended high MIS centres as compared 
with Asian or black patients (7.8% and 4.7%, respec-
tively), however, when black patients underwent surgery 




We have identified significant disparities in the rates of 
MIS in England forpatients undergoing hysterectomy in 
the NHS for EC/ECIS. Patients from the lowest socioeco-
nomic group and of non- white ethnicity and were signifi-
cantly less likely to undergo MIS as compared with white 
patients from more socially affluent areas. The differ-
ence in MIS rates was reduced when patients underwent 
surgery at high MIS providers, indicating that patient’s 
geographical location and local facilities to provide MIS 
is a factor in route of surgery for EC.
There are confounding factors that could help to 
explain the difference between the populations. The CCI 
score was significantly higher in the lower socioeconomic 
and black populations, which could have resulted in them 
being not suitable for MIS. Black ethnicity is known to 
be associated with a higher incidence and size of uterine 
fibroids as compared with white women,25 which again 
could have contribute to a higher OH rate by making MIS 
Figure 2 Providers MIS rate classification by region. The 
proportion, by region, of providers classified as having high, 
intermediate, low and very low MIS rates (very low 0%–
25% MIS rate, low 26%–50% MIS rate, intermediate 51%–
75% MIS rate, high 76%–100% MIS rate). MIS, minimally 
invasive surgery.
Figure 3 Funnel plot of MIS rate and number of cases 
performed for 2017. The proportion of hysterectomies 
performed by MIS by the total number of hysterectomies for 
each provider that performed at least one hysterectomy in 
2017. Each provider is also classified by their region and an 
average value for each region is plotted. two thresholds are 
for 50% and 70% MIS rate. MIS, minimally invasive surgery.
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not technically feasible, and non- white ethnicity has been 
identified as a risk factor for conversion to open surgery.26 
The previous abdominal surgery rate is also not well 
recorded in the HES data, therefore, patients who have 
undergone extensive surgery previously would also not 
have been appropriate for MIS. Similarly, the presence of 
fibroids that would preclude MIS is not recorded on HES 
and would depend on the size/location of the fibroid as 
well as the experience of the surgical team in performing 
MIS. However, if these were the only reasons for the 
disparity it does not explain why the MIS rate increases in 
patients from the lowest socioeconomic group or of black 
ethnicity undergoing surgery at high MIS providers.
Unlike in cervical cancer,27 28 there has not been shown 
to be a difference in long- term oncological outcome of 
the use of MIS as compared with OH in EC.7 The periop-
erative death rate associated with OH is known to be 
significantly higher as compared with MIS, however, we 
have shown the magnitude of the difference is much 
greater than previously reported. Wright et al, in his anal-
ysis of 6304 patients from the SEER database (2006–2011) 
identified an OR of death by 30 days for OH as compared 
with MIS of 0.57 (95% CI 0.34 to 0.95),22 whereas in our 
study a threefold increase risk of death was found with 
OH compared with MIS (OR 0.34; 95% CI 0.18 to 0.62).
The patients who died following surgery were older 
and more comorbid than the population that survived 
and as such may have been deemed unsuitable for MIS, 
although this could only be determined on an individual 
case by case basis. The age of patients undergoing MIS 
has increased across all regions since 2012 indicating that 
surgical teams have gained experience and are aware of 
the benefits and evidence supporting the use of MIS in 
the elderly population.29 Patient comorbidities, as deter-
mined by CCI, do however appear to influence MIS 
rates, with only the high/intermediate MIS providers 
demonstrating a rise in the CCI level of their cases over 
time, suggesting that one reason why there is such a 
high proportion of MIS cases in some centres is because 
they undertake cases MIS that other centres may deem 
unsuitable or too high risk for MIS. This highlights the 
challenges of operating on patients with medical comor-
bidities since surgical risk is not confined to the technical-
ities of the surgery but encompasses the patient’s entire 
perioperative care, including preoperative optimisation, 
anaesthetic procedure and postoperative mobilisation, 
nutrition and recovery. In particular, the anaesthetic 
experience and high- dependency unit support to under-
take challenging cases MIS may be lacking in hospitals 
only performing a small number of EC/ECIS cases per 
year, which may in turn contribute to the significantly 
lower MIS rates in these centres.30
Sharing expertise and providing support and mentor-
ship for low MIS providers through local cancer centre/
unit networks could help increase the overall MIS rates, 
however, the introduction of a national best practice 
target in England may help to focus resources on this 
population so that patients from all backgrounds and 
areas can benefit. MIS rates for EC have been proposed a 
quality indicator,31 and the target set in Scotland has been 
raised from 50% in 2014 to 70% in 2018, reflecting the 
change in clinical practice.32 We have shown that in 2017 
only 56% of providers reached the 70% threshold, there-
fore, much greater support for gynaecologists and their 
surgical teams will be needed in order for the majority of 
providers in England to achieve this target. Although the 
95% MIS rate achieved in Denmark33 would suggest that 
this target could be set even higher, thereby impacting on 
the significantly higher mortality seen with OH, and act 
as an incentive for individual providers to analyse their 
cases and strive to increase their proportion of MIS proce-
dures further. If improvements cannot be made in the low 
Figure 4 MIS/OH rate at patient ethnicity by providers MIS rate classification. Comparison of the percentage split between 
MIS and OH at each of the MIS rate classifications by patient ethnicity (very low 0%–25% MIS rate, low 26%–50% MIS rate, 
intermediate 51%–75% MIS rate, high 76%–100% MIS rate). MIS, minimally invasive surgery; OH, open hysterectomy.
8 Moss EL, et al. BMJ Open 2020;10:e036222. doi:10.1136/bmjopen-2019-036222
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MIS rate seen in some of the very low volume providers 
it does raise the argument as to whether a minimum 
annual caseload should be introduced for hospitals, 
with further centralisation of EC surgical management 
to larger providers, in order to increase access to MIS. 
Referral to larger providers may impact on overall MIS 
rates, however, it could result in greater disruption and 
burden to the patient rather than being treated by their 
local provider since, as already discussed, this population 
may be elderly and comorbid.
Strengths and limitations
The main strength of this study is that it is population 
based and the large number of procedures has enabled 
trends to be identified that may not have been seen in 
smaller datasets. It should be noted that HES data only 
covers NHS‐funded care in England, therefore, data on 
hysterectomies undertaken outside of the NHS were not 
included in this study. Despite its limitations, in partic-
ular the lack of cancer stage information and potential 
recording or adjudication errors, the ethnicity data in 
HES data are known to be reliable and match the UK 
population.32 The lack of staging data means that it is 
not possible to identify the small proportion of cases that 
would have undergone more extensive open cytoreduc-
tive surgery, which would be associated with a substan-
tially higher morbidity/mortality rate than an MIS 
staging procedure. Cytoreductive procedures would only 
have taken place at designated cancer centres due to the 
location of specialist gynaecological oncology surgeons, 
and therefore, such procedures will not have impacted 
the rate of open surgery or outcomes from cancer units. 
Despite a lack of stage data the pelvic lymphadenectomy 
rate is known and has been included, which was compa-
rable across the groups (18.4% in OH, 14.6% in LH and 
25.3% in RH).
The reliability of the coding might have changed over 
time although there was no evidence of changes in treat-
ment coding or significant changes in the underlying 
study population. Another limitation relates to the sensi-
tivity of IMD quintiles matched to each LSOA. Moreover, 
within each LSOA, there may be significant variation 
in terms of deprivation and therefore future research 
should assess deprivation at an individual level
Confining the survival analysis to 90 days following 
surgery aimed to capture procedure related rather than 
disease- specific deaths, although since stage data are not 
available, it is possible some of the deaths may have been 
due to disease progression rather as a result of surgery.
Interpretation
Disparities exist in the use of MIS for the treatment of 
EC/ECIS in England. Further investigation of patient- 
level data, preference elicitation studies and qualitative 
research are needed to understand the potential barriers 
to MIS in clinical practice and to improve access so that 
as many patients as possible can benefit from the reduced 
morbidity and mortality associated with MIS.
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